Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Number of holders
-
53
-
Total 13F shares, excl. options
-
8,718,962
-
Shares change
-
+1,174,354
-
Total reported value, excl. options
-
$32,953,841
-
Value change
-
+$4,430,716
-
Number of buys
-
36
-
Number of sells
-
-11
-
Price
-
$3.78
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q1 2021
59 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q1 2021.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 53 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,718,962 shares
of 107,573,681 outstanding shares and own 8.11% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (2,673,625 shares), BlackRock Inc. (1,925,167 shares), VANGUARD GROUP INC (635,124 shares), MORGAN STANLEY (592,081 shares), GEODE CAPITAL MANAGEMENT, LLC (493,796 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (432,100 shares), STATE STREET CORP (427,092 shares), NORTHERN TRUST CORP (305,023 shares), Nuveen Asset Management, LLC (167,875 shares), and Bank of New York Mellon Corp (89,953 shares).
This table shows the top 53 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.